MG53 suppresses interferon-β and inflammation via regulation of ryanodine receptor-mediated intracellular calcium signaling

TRIM family proteins play integral roles in the innate immune response to virus infection. MG53 (TRIM72) is essential for cell membrane repair and is believed to be a muscle-specific TRIM protein. Here we show human macrophages express MG53, and MG53 protein expression is reduced following virus infection. Knockdown of MG53 in macrophages leads to increases in type I interferon (IFN) upon infection. MG53 knockout mice infected with influenza virus show comparable influenza virus titres to wild type mice, but display increased morbidity accompanied by more accumulation of CD45+ cells and elevation of IFNβ in the lung. We find that MG53 knockdown results in activation of NFκB signalling, which is linked to an increase in intracellular calcium oscillation mediated by ryanodine receptor (RyR). MG53 inhibits IFNβ induction in an RyR-dependent manner. This study establishes MG53 as a new target for control of virus-induced morbidity and tissue injury.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Nature communications - 11(2020), 1 vom: 17. Juli, Seite 3624

Sprache:

Englisch

Beteiligte Personen:

Sermersheim, Matthew [VerfasserIn]
Kenney, Adam D [VerfasserIn]
Lin, Pei-Hui [VerfasserIn]
McMichael, Temet M [VerfasserIn]
Cai, Chuanxi [VerfasserIn]
Gumpper, Kristyn [VerfasserIn]
Adesanya, T M Ayodele [VerfasserIn]
Li, Haichang [VerfasserIn]
Zhou, Xinyu [VerfasserIn]
Park, Ki-Ho [VerfasserIn]
Yount, Jacob S [VerfasserIn]
Ma, Jianjie [VerfasserIn]

Links:

Volltext

Themen:

77238-31-4
Interferon-beta
Journal Article
MG53 protein, mouse
Membrane Proteins
NF-kappa B
RNA, Small Interfering
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Ryanodine Receptor Calcium Release Channel
TRIM72 protein, human
Tripartite Motif Proteins
Video-Audio Media

Anmerkungen:

Date Completed 09.09.2020

Date Revised 09.04.2024

published: Electronic

Citation Status MEDLINE

doi:

10.1038/s41467-020-17177-6

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM312573642